Scandinavian Real Heart
0.283 SEK +0.71%Be the first to follow this company
Scandinavian Real Heart operates in medical technology. Today, the company's main focus is on research and development of heart pumps used among patients with severe heart conditions who are in the queue for transplant. The idea behind the heart pump is to use the product as a transitional solution before a final heart transplant is performed. The company is based in Västerås.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
HEART
Daily low / high price
0.28 / 0.292
SEK
Market cap
58.53M SEK
Turnover
48.63K SEK
Volume
169K
Financial calendar
Interim report
22.08.2024
Interim report
14.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
European Innovation Council Accelerator | 18.9 % | 18.9 % |
Eskilstunahem Förvaltnings AB | 8.1 % | 8.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Realheart performs a directed issue of units to underwriters in connection with the completed rights issue
Scandinavian Real Heart AB Announces Outcome in the Company’s Rights Issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools